These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 12379363)

  • 21. Enrichment of anti-glomerular antigen antibody-producing cells in the kidneys of MRL/MpJ-Fas(lpr) mice.
    Sekine H; Watanabe H; Gilkeson GS
    J Immunol; 2004 Mar; 172(6):3913-21. PubMed ID: 15004199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The anti-La response of a single MRL/Mp-lpr/lpr mouse: specificity for DNA and VH gene usage.
    Bloom DD; St Clair EW; Pisetsky DS; Clarke SH
    Eur J Immunol; 1994 Jun; 24(6):1332-8. PubMed ID: 8206093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Terminal deoxynucleotidyl transferase deficiency decreases autoimmune disease in MRL-Fas(lpr) mice.
    Feeney AJ; Lawson BR; Kono DH; Theofilopoulos AN
    J Immunol; 2001 Sep; 167(6):3486-93. PubMed ID: 11544342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cloning of B cells from autoimmune MRL-lpr/lpr and MRL.xid mice.
    Pisetsky DS; Caster SA; Piper M; Scott DW; Steinberg AD
    Cell Immunol; 1984 Mar; 84(1):32-40. PubMed ID: 6607779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A structural basis for transition-state stabilization in antibody-catalyzed hydrolysis: crystal structures of an abzyme at 1. 8 A resolution.
    Kristensen O; Vassylyev DG; Tanaka F; Morikawa K; Fujii I
    J Mol Biol; 1998 Aug; 281(3):501-11. PubMed ID: 9698565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the crystallographic structures of two catalytic antibodies with esterase activity.
    Buchbinder JL; Stephenson RC; Scanlan TS; Fletterick RJ
    J Mol Biol; 1998 Oct; 282(5):1033-41. PubMed ID: 9753552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoimmune CD4+ T cells interfere with immune tolerance to a thymic-independent antigen.
    Miller ML; Chacko JA
    J Immunol; 1988 Jun; 140(12):4108-14. PubMed ID: 3286767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA-hydrolyzing antibodies from sera of autoimmune-prone MRL/MpJ-lpr mice.
    Dubrovskaya VV; Andryushkova AS; Kuznetsova IA; Toporkova LB; Buneva VN; Orlovskaya IA; Nevinsky GA
    Biochemistry (Mosc); 2003 Oct; 68(10):1081-8. PubMed ID: 14616078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural basis for amide hydrolysis catalyzed by the 43C9 antibody.
    Thayer MM; Olender EH; Arvai AS; Koike CK; Canestrelli IL; Stewart JD; Benkovic SJ; Getzoff ED; Roberts VA
    J Mol Biol; 1999 Aug; 291(2):329-45. PubMed ID: 10438624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-P autoantibody production requires P1/P2 as immunogens but is not driven by exogenous self-antigen in MRL mice.
    Hines JJ; Weissbach H; Brot N; Elkon K
    J Immunol; 1991 May; 146(10):3386-95. PubMed ID: 2026870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Site-directed mutagenesis of a catalytic antibody: an arginine and a histidine residue play key roles.
    Stewart JD; Roberts VA; Thomas NR; Getzoff ED; Benkovic SJ
    Biochemistry; 1994 Mar; 33(8):1994-2003. PubMed ID: 8117656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unusual germline DSP2 gene accounts for all apparent V-D-D-J rearrangements in newborn, but not adult, MRL mice.
    Kompfner E; Oliveira P; Montalbano A; Feeney AJ
    J Immunol; 2001 Dec; 167(12):6933-8. PubMed ID: 11739512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Functional analysis of an autoantigen reactive B cell clone derived from MRL/MP-lpr/lpr mice].
    Kobayashi K; Hamano T; Kakishita E
    Ryumachi; 1996 Dec; 36(6):844-55. PubMed ID: 9122824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The induction of tolerance and suppression in autoimmune MRL mice using hapten-modified self.
    Santoro TJ; Scott DW; Pisetsky DS
    J Immunol; 1981 Aug; 127(2):690-3. PubMed ID: 7252156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypogammaglobulinaemia occurs in Fas-deficient MRL-lpr mice following deletion of MHC class II molecules.
    Anderson CC; Mukherjee R; Sinclair NR; Jevnikar AM
    Clin Exp Immunol; 1997 Sep; 109(3):473-9. PubMed ID: 9328125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Innate antibody catalysis.
    Gololobov G; Sun M; Paul S
    Mol Immunol; 1999 Dec; 36(18):1215-22. PubMed ID: 10684961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural antibodies that react with V-region peptide epitopes of DNA-binding antibodies are made by mice with systemic lupus erythematosus as disease develops.
    Ward FJ; Knies JE; Cunningham C; Harris WJ; Staines NA
    Immunology; 1997 Nov; 92(3):354-61. PubMed ID: 9486108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of covalent binding antibodies.
    Armentano F; Knight T; Makker S; Tramontano A
    Immunol Lett; 2006 Feb; 103(1):51-7. PubMed ID: 16297987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.
    Mannoor K; Matejuk A; Xu Y; Beardall M; Chen C
    J Immunol; 2012 Apr; 188(8):3628-38. PubMed ID: 22407922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Catalytic antibodies in clinical and experimental pathology: human and mouse models.
    Ponomarenko NA; Durova OM; Vorobiev II; Aleksandrova ES; Telegin GB; Chamborant OG; Sidorik LL; Suchkov SV; Alekberova ZS; Gnuchev NV; Gabibov AG
    J Immunol Methods; 2002 Nov; 269(1-2):197-211. PubMed ID: 12379362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.